Gujarat Kidney and Super Speciality MD, chairman, board of directors and AGM
NSE: GKSLBSE: 544666Healthcare ServicesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹179.46.
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,391 Cr1,531st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 Jul 2026
- 5.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Dec 2025
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 8.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 Jul 2026
- 0.06
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 5,64,91540.6% delivered
Gujarat Kidney and Super Speciality board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.
- Chairperson and managing directorPragnesh Yashwantsinh Bharpoda
6 directors3 independent2 executive1 non-executive
- Pragnesh Yashwantsinh Bharpoda · Chairperson and managing directorExecutive · joined Sep 2023 · reappointed Jan 2025 · 1 listed board · 1 committee seat
- Bhartiben Pragnesh BharpodaExecutive · joined Dec 2019 · reappointed Jan 2025 · 1 listed board
- Anitaben Yashvantsinh BharpodaNon-executive · joined Dec 2019 · 1 listed board
- Jagdishbhai Vinodchandra ThakkarIndependent · joined Dec 2024 · reappointed Dec 2024 · 18 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- Udayan Maheshkant KachchhiIndependent · joined Dec 2024 · reappointed Dec 2024 · 18 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- Kairavi Naimesh ShahIndependent · joined Dec 2024 · reappointed Dec 2024 · 18 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 27 Jun 20266 of 6 present3 independent · 29 days in between
- 28 May 20265 of 6 present2 independent · 30 days in between
- 27 Apr 20266 of 6 present3 independent · 38 days in between
- 19 Mar 20266 of 6 present3 independent · 32 days in between
4 earlier meetings
- 14 Feb 20266 of 6 present3 independent · 8 days in between
- 5 Feb 20266 of 6 present3 independent · 29 days in between
- 6 Jan 20266 of 6 present3 independent · 3 days in between
- 2 Jan 20266 of 6 present3 independent
Audit Committee
Chair Jagdishbhai Vinodchandra Thakkar
Kairavi Naimesh Shah, Udayan Maheshkant Kachchhi, Pragnesh Yashwantsinh Bharpoda
- 27 Jun 20264 of 4 present3 independent · 29 days in between
- 28 May 20263 of 4 present2 independent · 69 days in between
- 19 Mar 20264 of 4 present3 independent · 32 days in between
- 14 Feb 20264 of 4 present3 independent · 8 days in between
3 earlier meetings
- 5 Feb 20264 of 4 present3 independent · 30 days in between
- 5 Jan 20264 of 4 present3 independent · 2 days in between
- 2 Jan 20264 of 4 present3 independent
Nomination and remuneration committee
Chair Kairavi Naimesh Shah
Udayan Maheshkant Kachchhi, Jagdishbhai Vinodchandra Thakkar
- 28 May 20262 of 3 present2 independent · 30 days in between
- 27 Apr 20263 of 3 present3 independent · 114 days in between
- 2 Jan 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair Udayan Maheshkant Kachchhi
Kairavi Naimesh Shah, Jagdishbhai Vinodchandra Thakkar
- 14 Feb 20263 of 3 present3 independent
Corporate Social Responsibility Committee
Chair Pragnesh Yashwantsinh Bharpoda
Jagdishbhai Vinodchandra Thakkar, Udayan Maheshkant Kachchhi
- 28 May 20262 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- Y M Shah & CoPeer-review certificate valid to Jun 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Gujarat Kidney and Super Speciality AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Gujarat Kidney and Super Speciality share news and announcements
Annual general meeting, 28 Sep 2026
12,948 shareholders on the register on 21 Sep 2026; present: 5 promoters and 25 others; votes counted by Ashish Doshi / SPANJ & Associates.The company's voting result (opens in a new tab)
- Adoption of Standalone and Consolidated Financial Statements for the FY 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Appointment of Mrs Anita Bharpoda (DIN:08644747) Director retiring by rotationOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Appointment of Secretarial AuditorOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Appointment of Mr Paresh Dhoti (DIN:10387032) as an Independent DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Appointment of Mrs Disha Bharpoda (DIN:11897794) as an Independent DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approval of Revision in Remuneration of Mr Pragnesh Bharpoda (DIN: 01033141), Managing DirectorSpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approval of Revision in Remuneration of Mrs. Bharti Bharpoda (DIN: 08644746), Wholetime DirectorSpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approval under section 180 (1)(c) of the Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approval under section 180 (1)(a) of the Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approve increase in threshold of loans/ guarantees, providing of securities and making of investments in securities under section 186 of the Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approval to advance any loan/give guarantee/provide security under section 185 of the Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approve related party transactionsOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 22 Aug 2026, 1 resolution
13,678 shareholders on the register on 17 Jul 2026; votes counted by Ashish Doshi / SPANJ & Associates.The company's voting result (opens in a new tab)
- To consider and approve Variation in the Objects / terms of utilisation of the Initial Public Offering (“IPO”) proceeds.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.35%
Turnout: all 72.17% · promoters 100.00% · institutions 1.09% · other public 2.93%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 4 Jul 2026, 1 resolution
14,279 shareholders on the register on 29 May 2026; votes counted by Ashish Doshi / SPANJ & Associates.The company's voting result (opens in a new tab)
- Variation in the Objects / terms of utilisation of the Initial Public Offering (“IPO”) proceeds.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 72.16% · promoters 100.00% · institutions 0.90% · other public 3.00%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 25 Apr 2026, 3 resolutions
18,563 shareholders on the register on 20 Mar 2026; votes counted by Dharmendra Bhaliya / Dharmendra Bhaliya.The company's voting result (opens in a new tab)
- To consider and approve the Interim utilisation of Funds towards healthcare expansion aligned with the Companys Main IPO object.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.10% · promoters 100.00% · institutions 0.00% · other public 2.89%
- To approve voluntary revision of Financial Statements and Boards report under section 131 of Companies Act 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 72.10% · promoters 100.00% · institutions 0.00% · other public 2.89%
- To appoint Mr Dharmendra Bhaliya, Practising Company Secretary, as Secretarial Auditors of the Company for FY 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 72.10% · promoters 100.00% · institutions 0.00% · other public 2.89%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Fines
Reported in the filing for the quarter to Jun 2026.
- Fine or penaltyBSE LimitedSince 15 Apr 2026
Payment of fine of Rs. 10000 plus applicable taxes
Delay in furnishing prior intimation about the meeting of the board of directors under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) - Fine or penaltyNational Stock Exchange of India LimitedSince 15 Apr 2026
Payment of fine of Rs. 10000 plus applicable taxes
Delay in furnishing prior intimation about the meeting of the board of directors under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Proposed acquisition of “Parekhs Hospital Private Limited” at Ahmedabad | 77.00 | 77.00 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Part payment of purchase consideration for the already acquired hospital i.e. “Ashwini Medical Centre | 12.40 | 12.40 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Acquisition of additional shareholding in our subsidiary namely “Harmony Medicare Private Limited” at Bharuch | 10.78 | 10.78 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Healthcare expansion aligned with the company’s main IPO object, including development and operation of Mult speciality hospital project in Bharuch through a newly incorporated private company | 25.15 | 4.95 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Setting up and Operating Dialysis services through deployment of Dialysis machine and Digital patient Monitoring solution by way of collaborating with Lord’s Mark Industries Limited | 6.83 | 6.83 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by our Company | 1.20 | 1.20 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Funding inorganic growth through unidentified acquisitions and General Corporate Purposes. | 87.44 | 74.82 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | issue expenses | 25.05 | 24.63 | Yes |